CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Low-temperature photothermal irradiation triggers alkyl radicals burst for potentiating cancer immunotherapy.
Low-temperature photothermal irradiation triggers alkyl radicals burst for potentiating cancer immunotherapy.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
尽管低温光热治疗(PTT)可以使肿瘤对免疫检查点抑制敏感,但其在氧气和淋巴细胞浸润不足的深部和内部肿瘤中的疗效仍然受限。非氧依赖性烷基自由基已被证明可通过上调脂质过氧化和活性氧(ROS)协同增强PTT。
在此,提出了一种基于烷基自由基增强轻度PTT引起的免疫原性细胞死亡(ICD)的创新策略,以改善免疫治疗疗效不佳的问题,该策略由光热材料中国墨、偶氮引发剂2,2-偶氮双[2-(2-咪唑啉-2-酰基)丙烷]二盐酸盐(AIPH)和PD-L1抑制剂HY19991(HY)组成。在近红外-II激光照射下,低温(<45℃)刺激诱导肿瘤中免疫检查点受体(PD-L1)高表达,并触发AIPH产生大量烷基自由基。
值得注意的是,在轻度PTT将免疫冷肿瘤微环境转化为热肿瘤微环境后,烷基自由基增强了ICD并增加了TIL(肿瘤浸润淋巴细胞)对肿瘤的募集。释放的HY通过阻断活化T淋巴细胞与PD-L1的结合进一步增强了免疫治疗效果。体内研究表明,具有协同机制的一体化水凝胶具有非凡的能力,可逆转免疫抑制微环境,刺激先天性和适应性免疫应答以消除肿瘤并预防转移。
Although low-temperature photothermal therapy (PTT) can sensitize tumors to immune checkpoint inhibition, its efficacy is still restricted in the deep and internal tumors without enough oxygen and lymphocytic infiltration. Non-oxygen-dependent alkyl radicals have been demonstrated to synergistically enhance PTT through up-regulating lipid peroxidation and reactive oxygen species (ROS).
Herein, an innovative strategy based on alkyl radicals to augment immunogenetic cell death (ICD) caused by mild PTT was proposed to improve poor efficacy of immunotherapy, which composed of a photothermal material of Chinse ink, an azo-initiator of 2,2-azobis[2-(2-imidazoline-2-acyl)propane]dihydrochloride (AIPH) and a PD-L1 inhibitor of HY19991 (HY). Upon near-infrared-II laser irradiation, low-temperature (<45℃) stimulation induced a high expression of immune checkpoint receptor (PD-L1) in tumors and triggered a large amount alkyl radicals generated by AIPH.
Significantly, the alkyl radicals augmented the ICD and increased the recruitment of tumor-infiltrating lymphocytes against tumors after transformation of the immunologically cold tumor microenvironment into hot by mild PTT. The released HY further enhanced the immunotherapy effect by blocking the binding of activated T lymphocytes and PD-L1.
In vivo studies exhibited that the all-in-one hydrogel with synergistic mechanisms had an extraordinary ability to reverse the immunosuppressive microenvironment, stimulate innate and adaptive immune responses to eliminate tumors and prevent metastasis.
MEMBER ACCOUNT
登录成功会直接打开下一页。